TMC Life Sciences Bhd (KLSE:0101) — Market Cap & Net Worth
Market Cap & Net Worth: TMC Life Sciences Bhd (0101)
TMC Life Sciences Bhd (KLSE:0101) has a market capitalization of $188.05 Million (RM749.01 Million) as of September 16, 2026. Listed on the KLSE stock exchange, this Malaysia-based company holds position #16861 globally and #227 in its home market, demonstrating a -3.37% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying TMC Life Sciences Bhd's stock price RM0.43 by its total outstanding shares 1741882393 (1.74 Billion). Also see TMC Life Sciences Bhd asset portfolio for a full breakdown of the balance sheet.
TMC Life Sciences Bhd Market Cap History: 2015 to 2026
TMC Life Sciences Bhd's market capitalization history from 2015 to 2026. Data shows change from $302.19 Million to $188.05 Million (-2.21% CAGR). Also see TMC Life Sciences Bhd (0101) cash conversion ratio for how efficiently the company converts equity into cash flow.
TMC Life Sciences Bhd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how TMC Life Sciences Bhd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check TMC Life Sciences Bhd (0101) share price today for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
0.48x
TMC Life Sciences Bhd's market cap is 0.48 times its annual revenue
Latest Price to Earnings (P/E) Ratio
10.82x
TMC Life Sciences Bhd's market cap is 10.82 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2017 | $364.51 Million | $151.71 Million | $26.03 Million | 2.40x | 14.00x |
| 2018 | $311.86 Million | $169.04 Million | $27.80 Million | 1.84x | 11.22x |
| 2019 | $269.83 Million | $194.98 Million | $20.92 Million | 1.38x | 12.90x |
| 2020 | $284.44 Million | $184.09 Million | $15.93 Million | 1.55x | 17.86x |
| 2021 | $229.34 Million | $201.02 Million | $20.25 Million | 1.14x | 11.32x |
| 2022 | $273.90 Million | $243.77 Million | $41.39 Million | 1.12x | 6.62x |
| 2023 | $312.69 Million | $311.44 Million | $39.26 Million | 1.00x | 7.97x |
| 2024 | $218.66 Million | $346.42 Million | $40.65 Million | 0.63x | 5.38x |
| 2025 | $196.80 Million | $345.54 Million | $3.61 Million | 0.57x | 54.58x |
| 2026 | $188.05 Million | $393.03 Million | $17.38 Million | 0.48x | 10.82x |
Competitor Companies of 0101 by Market Capitalization
Companies near TMC Life Sciences Bhd in the global market cap rankings as of September 16, 2026. Review 0101 tangible net assets ratio to assess the quality of the company's equity after excluding intangible assets.
Key companies related to TMC Life Sciences Bhd by market ranking:
- HCA Healthcare, Inc. (NYSE:HCA): Ranked #288 globally with a market cap of $91.34 Billion USD.
- Fresenius SE & Co. KGaA (XETRA:FRE): Ranked #911 globally with a market cap of $29.19 Billion USD ( €24.97 Billion EUR).
- FRESENIUS SE+CO. ADR 1/4 (F:FREA): Ranked #1001 globally with a market cap of $26.87 Billion USD ( €22.98 Billion EUR).
- Tenet Healthcare Corporation (NYSE:THC): Ranked #1234 globally with a market cap of $20.93 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #288 | HCA Healthcare, Inc. | NYSE:HCA | $91.34 Billion | $423.82 |
| #911 | Fresenius SE & Co. KGaA | XETRA:FRE | $29.19 Billion | €45.39 |
| #1001 | FRESENIUS SE+CO. ADR 1/4 | F:FREA | $26.87 Billion | €10.20 |
| #1234 | Tenet Healthcare Corporation | NYSE:THC | $20.93 Billion | $260.85 |
TMC Life Sciences Bhd Historical Marketcap From 2015 to 2026
Between 2015 and today, TMC Life Sciences Bhd's market cap moved from $302.19 Million to $ 188.05 Million, with a yearly change of -2.21%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | RM188.05 Million | -4.44% |
| 2025 | RM196.80 Million | -10.00% |
| 2024 | RM218.66 Million | -30.07% |
| 2023 | RM312.69 Million | +14.16% |
| 2022 | RM273.90 Million | +19.43% |
| 2021 | RM229.34 Million | -19.37% |
| 2020 | RM284.44 Million | +5.41% |
| 2019 | RM269.83 Million | -13.48% |
| 2018 | RM311.86 Million | -14.45% |
| 2017 | RM364.51 Million | -10.33% |
| 2016 | RM406.50 Million | +34.52% |
| 2015 | RM302.19 Million | -- |
End of Day Market Cap According to Different Sources
On Sep 16th, 2026 the market cap of TMC Life Sciences Bhd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $188.05 Million USD |
| MoneyControl | $188.05 Million USD |
| MarketWatch | $188.05 Million USD |
| marketcap.company | $188.05 Million USD |
| Reuters | $188.05 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About TMC Life Sciences Bhd
TMC Life Sciences Berhad, an investment holding company, provides healthcare services in Malaysia. The company operates Thomson Hospital Kota Damansara hospital located in prime alcove of Kota Damansara. It is involved in providing multi-disciplinary tertiary care, traditional and complementary, obstetrics and gynaecology, fertility services; operating fertility centres and women clinics; propert… Read more